Alfresa Launches ¥15 Billion Share Buyback via Accelerated Repurchase

Alfresa Holdings ( (JP:2784) ) has provided an update.

Alfresa Holdings has approved a share repurchase of up to 6,307,800 common shares, representing about 3.5% of its outstanding stock, for a total of approximately ¥15 billion to enhance capital efficiency and boost shareholder returns. The buyback will be conducted on May 18, 2026, via the Tokyo Stock Exchange’s ToSTNeT-3 off-auction system at a benchmark price of ¥2,378 per share, with a significant portion structured as a fully committed accelerated share repurchase using Nomura Securities, underscoring the company’s commitment to swiftly executing a sizable capital allocation program.

By using the Japanese-style accelerated share repurchase, Alfresa aims to secure a high likelihood of completing the planned buyback even if ordinary market sell orders are limited, with the final number of shares potentially adjusted to reflect the average trading price over a set period. This approach is expected to immediately reduce the share float and signal management’s confidence in the company’s valuation, potentially supporting the stock price and reinforcing its shareholder-focused capital policy strategy.

The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2400.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.

More about Alfresa Holdings

Alfresa Holdings Corporation operates in Japan’s healthcare and pharmaceutical distribution industry, focusing on the wholesale distribution of prescription drugs and related medical products. The company plays a key role in the domestic pharmaceutical supply chain, serving hospitals, pharmacies, and other healthcare providers across the Japanese market.

Average Trading Volume: 353,006

Technical Sentiment Signal: Buy

Current Market Cap: Yen444.6B

See more data about 2784 stock on TipRanks’ Stock Analysis page.